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ABSTRACT: This study aims to determine the changes in serum homocysteine (Hcy) and nitric oxide (NO) concen-
trations in sheep naturally infected with F. hepatica. The animal material of the study consisted of a total of 50 sheep: 
40 sheep with fascioliasis and 10 healthy sheep.
The statistical analysis indicated that serum homocysteine concentrations, folate and vitamin B12 levels of the sheep 
infected with F. hepatica were higher than those of the control group (P<0.001 P<0.001 and P<0.05, respectively), 
whereas the nitric oxide levels of the sheep infected with F. hepatica were significantly lower than those of healthy 
sheep (P<0.001).
In conclusion, it is thought that vitamin B12 and folate are not used sufficiently for the conversion of homocysteine to 
methionine in the remethylation cycle due to the damage in the liver tissue of sheep naturally infected with F. hepatica. 
This results in the increase of homocysteine which in turn inhibits the formation of nitric oxide.
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INTRODUCTION
Turkey has about 31.507.934 sheep (Tuncer et al., 2017; Tuncer et al., 2018; Tuncer 2019) and is the 
7th greatest sheep raiser country in the world (Tuncer, 
2019). F. hepatica is a severe disease causing signifi-
cant economic losses in the countries across the world 
where sheep, goats, buffalo (Alvarez et al., 2009), and 
cattle are raised (Yang et al., 1998). This parasitic dis-
ease may cause failure to thrive, decrease in meat and 
milk production, and even death in animals (Souza 
et al., 2002; Alcala-Canto et al., 2007; Hodžić et al., 
2013). Young forms of the parasite destroy the pa-
renchymal tissue, and mature forms destroy the bile 
ducts (Benzer and Ozan, 2003). Many researchers 
have focused on changes in serum enzyme activities 
to determine the level, prognosis, and diagnosis of 
liver damage caused by F. hepatica (Kozat and Den-
izhan, 2010).
Homocysteine is an intermediate in methionine 
metabolism, which takes place mainly in the liver 
(Still and McDowell, 1998; García-Tevijano et al., 
2001; Kozat and Okman, 2017). Hcy is a sulfuric 
amino acid formed during the methionine metabolism 
and does not enter the primary structure of proteins 
(García-Tevijano et al., 2001; Fischer et al., 2003; 
Kozat and Okman, 2017). 70% of total homocyste-
ine in plasma is bound to protein. One-fourth of it is 
present as disulfide homocysteine by binding to each 
other, the rest as cysteine-homocysteine or homocys-
teine thiolactone (Kozat and Okman, 2017). Hcy is 
metabolized in two major metabolic pathways: the 
remethylation and transsulfuration cycle (Blom and 
Smulders, 2011). Hcy is converted to methionine with 
the addition of a methyl group in a reaction catalized 
by vitamin B12-dependent methionine synthase. The 
methyl donor can be either 5,10-methyltetrahydrofo-
late (MTHF) or betaine. The reaction of MTHF takes 
place in all tissues and is dependent on vitamin B 12. 
The reaction in which the betaine is the methyl donor 
takes place in the liver and kidney and is independent 
of vitamin B12. Methionine is converted to S-adenosyl 
methionine (SAM) in the presence of ATPand S-ade-
nosyl methionine synthetase. SAM acts as a methyl 
donor in many reactions. This methylation reaction 
results in S-adenosyl homocysteine (SAH). SAH is 
converted into Hcy by a reaction catalyzed by the en-
zyme hydrolase, and all reactions occur in the liver 
(Kozat and Okman, 2017). The liver plays a crucial 
role in sulfur amino acid metabolism. Therefore, Hcy 
metabolism may be impaired in chronic liver diseas-
es (Ventura et al., 2005).The sulfur-containing ami-
no acid methionine and its derivatives play a central 
role in the metabolism of homocysteine and cysteine. 
Chronic liver diseases and especially cirrhosis cause 
abnormalities in the methionine metabolism, which 
reflects disorders in multiple enzyme levels. Disorders 
in methionine demethylation, transsulfuration and 
remethylation of homocysteine, as well as cystathi-
onine synthesis and hydrolysis, have been described 
both at the functional and genetic levels throughout 
the natural course of chronic liver diseases (Ventura et 
al., 2005; Kozat and Okman, 2017). Increases in total 
homocysteine levels, that is, the role of homocysteine 
in atherogenesis, atherosclerosis and thrombosis in 
hyperhomocysteinemia, cause cardiovascular system 
disease (Cayir and Kozat, 2016). Hyperhomocystein-
emia leads directly to vascular endothelial damage; 
endothelin changes the anticoagulant effect to pro-
coagulant and causes proliferation of smooth muscle 
cells (Temel and Ezerol, 2002). Some researchers 
have reported that the release of nitric oxide (NO), 
a potent vasodilator and platelet aggregation inhibi-
tor, from bovine endothelium is inhibited by Hcy and 
inhibition and/or reduction of NO release may cause 
thrombotic events in hyperhomocysteinemia (Kerke-
ni et al., 2006).
This study was carried out to determine whether 
the Hcy remethylation mechanism was affected in 
sheep that were naturally infected with F. hepatica. 
Moreover, it aimed to determine whether there is a 
relationship between serum homocysteine values and 
NO changes in liver disorders.
MATERIALS AND METHODS
Animals
This study was conducted on all sheep that 
came from one farm: 40 sheep with fascioliasis 
and 10 healthy sheep. This research was approved 
(07/03/2017 and 27552122-604.01.02-E.16823) by 
the Animal Research Ethics Committee of Van Yuzu-
ncu Yil University in Van, Turkey.
At the beginning of the study, all the animals were 
subjected to general clinical examination and the 
body temperature, respiratory rate, and heart rate of 
all sheep were recorded. At the end of the clinical ex-
aminations of sheep, approximately 30-50 g of faeces 
were taken from the rectum of each sheep and placed 
in the faeces collection containers. Samples were 
numbered according to the pedigree chart. Faecal 
samples were taken to the laboratory and kept at -20 
°C until examinion. Benedek’s sedimentation method 
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was used to examine the samples (Toparlak and Tu-
zer, 1994) and determine determine which sheep were 
infected with F. hepatica and which were healthy.
Homocysteine measurements
Sera from blood samples were collected and ho-
mocysteine levels in serum healthy sheep and the 
sheep infected with fascioliasis were determined by 
ELISA device (ELISA reader®-DAS).
Nitric oxide measurements
Suitable Nitrate/nitrite for sheep was determined 
by ELISA device (ELISA reader®-DAS) using the 
colourimetric assay kit (Cayman Chemical Company, 
catalogue No. 780001/USA).
Vitamin B12 and Folate measurements
Vitamin B 12 and Folate levels in serum samples 
were determined by autoanalyser (Elecyc 2010 Roche 
Hitachi-Japan).
Statistical Analysis
Descriptive statistics for the measured parame-
ters are expressed as Mean, Standard Deviation. To 
compare the groups, Student’s t-test was performed. 
The statistical significance level was taken as 5% and 
SPSS (ver: 21) statistical package program was used 
for calculations.
RESULTS
Table 1 shows the statistical analysis of the mea-
surements of serum Hcy, NO concentrations, folate 
and vitamin B12 levels of healthy sheep and sheep 
infected with F. hepatica. Homocysteine concen-
trations, folate and vitamin B12 levels of the sheep 
infected with F. hepatica were higher than those of 
the control group (P < 0.001, P < 0.001 and P<0.05, 
respectively), whereas the nitric oxide levels of the 
sheep infected with F. hepatica were significantly 
lower than those of healthy sheep (P < 0.001).









Hcy (pg/ml) 5.83±0.93 9.99±2.99 .001
Vit B12 (pg/ml) 1227.25±431.16 1552.75±450,74 .05
Folate (ng/ml) 1.56±0.31 2.34±0.54 .001
NO (µmol/L) 53.19±7.20 34.15±15.82 .001
DISCUSSION
The purpose of this study was to investigate the 
changes in serum Hcy and NO concentrations of 
sheep infected with F. hepatica. The liver plays a key 
role in the synthesis and metabolism of Hcy, which 
is an essential intermediate metabolite of methionine 
metabolism. Methionine is largely metabolized in 
this organ. The liver has activated genes involved in 
the methionine and homocysteine metabolism. MAT 
(Methionine adenosyltransferases), which plays a 
role in the homocysteine metabolism is found only 
in the liver, whereas the majority of BHMT (Beta-
ine-homocysteine methyltransferase) and CBS (Cys-
tathionine β-synthetase) are synthesized in the liver 
((Finkelstein, 1990; James et al., 1999). For these rea-
sons, damage of the liver affects the metabolism of 
homocysteine (Paxton et al., 1986; Ciftci and Yuce, 
2013). It has been reported that the mean plasma ho-
mocysteine levels in human patients with cirrhosis 
were much higher than in healthy controls, and there 
was a statistically significant difference between the 
homocysteine plasma values in patients with cirrhosis 
and healthy subjects (Ćulafić et al., 2013). In another 
study a disorder in the liver is thought to cause dis-
orders in Hcy metabolism. Plasma Hcy levels in fat-
ty liver patients are higher than in nonalcoholic and 
healthy individuals (de Carvalho et al., 2013). It is 
thought that basal hyperhomocysteinemia in cirrho-
sis is due to impaired transsulfuration and remeth-
ylation mechanisms (Duce et al., 1988; Look et al., 
2000; Bosy-Westphal et al., 2001). In human studies 
it has also been reported that homocysteine metabo-
lism is impaired in chronic liver diseases and leads 
to an increase in baseline hyperhomocysteinemia in 
hepatitis patients by 34%, in the fatty liver by 50%, 
in patients with cirrhosis by 54% and in 52% after 
orthotopic liver transplantation (Bosy-Westphal et 
al., 2003). When we examined the Hcy results from 
sheep infected with fascioliasis in this study (Table 
1), serum homocysteine levels were significantly 
higher (P < 0.01) than in the control group. For these 
reasons, significant changes occur in the metabolism 
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of Hcy when the liver is damaged. These results are 
consistent with literature findings indicating that ho-
mocysteine levels are high in living organisms with 
liver damage (Paxton et al., 1986; Ćulafić et al., 2013; 
James et al., 1999; Ciftci and Yuce, 2013). There is 
a reported relationship between serum / plasma Hcy 
levels and folate and vitamin B12 levels. (Klee, 2000; 
Blom and Smulders, 2011; Kozat and Okman, 2017). 
Hcy is increased in the plasma of patients with defi-
ciency in vitamin B12 or folate (Klee, 2000). In this 
study, Hcy concentrations, folate and vitamin B12 
levels of the sheep infected with F. hepatica were 
higher than those of the control group (P < 0.001, P < 
0.001 and P<0.05, respectively). High concentrations 
of Hcy are consistent with increases in serum folate 
and vitamin B12 levels. A significant increase in ho-
mocysteine concentrations of sheep infected with F. 
hepatica can be attributed to the deterioration of the 
mechanism of remethylation due to inadequate use of 
folate and Vitamin B12 as a result of liver damage
Some researchers have reported that the release of 
nitrite oxide (NO), a potent vasodilator and platelet 
aggregation inhibitor, from bovine endothelial cells 
is inhibited by homocysteine (Danishpajooh et al., 
2001). Several studies have confirmed that the bio-
availability of NO is decreased in hyperhomocystein-
emia (Fisher et al., 2003; Stanger and Weger, 2003), 
which might be attributable to diminished NO pro-
duction or to alternative mechanisms such oxidative 
stress or nitrosylation (Fisher et al., 2003; Stanger 
and Weger, 2003, Dayal et al., 2004; Kerkeni et al., 
2006). Many studies have been conducted on changes 
in NO levels in liver disorders (Gupta et al., 1998; 
Cervi et al., 1998; Clemens, 1999; Benzer and Ozan, 
2003; Chen et al., 2003). In a study investigating the 
functional role of vascular endothelium on increased 
vascular tone in intrahepatic microcirculation in rats 
with experimental cirrhosis; a decrease was reported 
in endothelial dysfunction and NO production in in-
trahepatic microcirculation of cirrhotic rats (Gupta et 
al., 1998). Another study investigated the prolifera-
tive responses of spleen cells against mitogens in F. 
hepatica -infected rats and reported a decrease in the 
amount of NO produced, and this decrease was partly 
associated with extra secretory antigens of F. hepatica 
(Cervi et al., 1998). A study examining lipid peroxi-
dation, antioxidant enzymes and nitric oxide levels in 
the sheep infected with F. hepatica compared the re-
sults with those of healthy sheep and reported that se-
rum NO levels of the sheep infected with F. hepatica 
were not affected but there was a significant decrease 
in NO levels in the liver disease (Benzer and Ozan, 
2003). Some experimental and clinical studies have 
reported that hyperhomocysteinemia causes vascular 
oxidative stress and disrupts the vascular response to 
NO, indicating endothelial dysfunction in rats (Gupta 
et al., 1998). It has also been reported that homocys-
teine reacts with NO and inhibits not only the biolog-
ical activity of endothelium-derived NO but also the 
biological activity of exogenously supplied NO (Nap-
po et al., 1999; Fu et al., 2002). In this study, serum 
NO levels of sheep with fascioliasis were found to be 
significantly lower than serum NO levels of healthy 
sheep. The decrease in NO levels in the infected sheep 
is consistent with the data reported by the researchers 
(Cervi et al., 1998; Gupta et al., 1998). Furthermore, 
in the sheep infected with F. hepatica, homocysteine 
concentrations were found to be significantly higher 
(P < 0.001) while nitric oxide levels were found to 
be lower than in healthy sheep (P < 0.001). Hyper-
homocysteinemia and decreased NO concentration in 
the diseased group support the data of the research-
ers (Still and McDowell, 1998; Bosy-Westphal et al., 
2003; Fisher et al., 2003; Stanger and Weger, 2003; 
Dayal et al., 2004; Kerkeni et al., 2006; Ćulafić et al., 
2013).
In conclusion, homocysteine, folate and vitamin 
B12 changes can be caused by the following reasons: 
1) It is thought that F. hepatica infection causes severe 
damage in the liver, which, in turn, leads to the deteri-
oration of functions and disruption in the conversion 
of homocysteine to methionine, and, as a result, caus-
es hyperhomocysteinemia, 2) Folate and Vitamin B 12 
levels were found to be high in the fascioliasis group 
because folate and Vitamin B12, used as cofactors in 
the conversion of homocysteine to methionine due to 
functional disorders in the liver, are not used suffi-
ciently, 3) Low NO level in the diseased group may 
be due to intrahepatic vascular endothelial disorder or 
may be due to the inhibition of NO synthesis due to 
the increase of Hcy.
The present study concludes that there is a nega-
tive correlation between serum Hcy values and NO 
values in liver disorders caused by F. hepatica. Be-
sides, since the present study is the first study to pres-
ent evidence with regards to hyperhomocysteinemia 
in liver damage, it is thought that it will promote fu-
ture research on liver damage.
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